MX2018008190A - Sistemas y metodos para la administracion transdermica a largo plazo. - Google Patents

Sistemas y metodos para la administracion transdermica a largo plazo.

Info

Publication number
MX2018008190A
MX2018008190A MX2018008190A MX2018008190A MX2018008190A MX 2018008190 A MX2018008190 A MX 2018008190A MX 2018008190 A MX2018008190 A MX 2018008190A MX 2018008190 A MX2018008190 A MX 2018008190A MX 2018008190 A MX2018008190 A MX 2018008190A
Authority
MX
Mexico
Prior art keywords
systems
methods
long term
transdermal administration
term transdermal
Prior art date
Application number
MX2018008190A
Other languages
English (en)
Inventor
Singh Parminder
Soo Lee Eun
K Jain Amit
Original Assignee
Corium Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corium Int Inc filed Critical Corium Int Inc
Publication of MX2018008190A publication Critical patent/MX2018008190A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches

Abstract

Se proporcionan dispositivos, sistemas, composiciones y métodos para la administración transdérmica a largo plazo o prolongada de un agente activo.
MX2018008190A 2015-12-30 2016-12-30 Sistemas y metodos para la administracion transdermica a largo plazo. MX2018008190A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562273288P 2015-12-30 2015-12-30
US201662367055P 2016-07-26 2016-07-26
PCT/US2016/069558 WO2017117554A1 (en) 2015-12-30 2016-12-30 Systems and methods for long term transdermal administration

Publications (1)

Publication Number Publication Date
MX2018008190A true MX2018008190A (es) 2018-11-12

Family

ID=57861282

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018008190A MX2018008190A (es) 2015-12-30 2016-12-30 Sistemas y metodos para la administracion transdermica a largo plazo.

Country Status (12)

Country Link
US (6) US10835499B2 (es)
EP (1) EP3397250A1 (es)
JP (1) JP6833855B2 (es)
KR (1) KR20180127315A (es)
CN (1) CN108697655B (es)
AU (2) AU2016381351B2 (es)
CA (1) CA3010183A1 (es)
IL (2) IL260290B2 (es)
MX (1) MX2018008190A (es)
RU (1) RU2737464C2 (es)
SG (1) SG11201805570WA (es)
WO (1) WO2017117554A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10213586B2 (en) 2015-01-28 2019-02-26 Chrono Therapeutics Inc. Drug delivery methods and systems
AU2016228779A1 (en) 2015-03-12 2017-09-07 Chrono Therapeutics Inc. Craving input and support system
US10835499B2 (en) * 2015-12-30 2020-11-17 Corium, Inc. Systems and methods for long term transdermal administration
CN109922796B (zh) 2016-06-23 2023-04-07 考里安有限责任公司 具有亲水和疏水域的粘合剂基质和治疗剂
EP3490544A1 (en) * 2016-07-27 2019-06-05 Corium International, Inc. Memantine transdermal delivery systems
US20180028461A1 (en) 2016-07-27 2018-02-01 Corium International, Inc. Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
US9993466B2 (en) 2016-07-27 2018-06-12 Corium International, Inc. Donepezil transdermal delivery system
AU2018205529B2 (en) 2017-01-06 2023-08-10 Morningside Venture Investments Limited Transdermal drug delivery devices and methods
US20180303764A1 (en) * 2017-04-19 2018-10-25 Inep Europe Sarl Method for manufacturing a transdermal device
US11052054B2 (en) * 2017-04-19 2021-07-06 Inep Europe Sarl Method for manufacturing a transdermal device
KR20200032153A (ko) * 2017-07-26 2020-03-25 코리움, 인크. 용매가 채워진 공극을 가진 미세다공성 막을 구비한 경피 전달 시스템
US11173132B2 (en) 2017-12-20 2021-11-16 Corium, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
CA3101966A1 (en) 2018-05-29 2019-12-05 Morningside Venture Investments Limited Drug delivery methods and systems
CN109432061B (zh) * 2018-11-09 2020-10-30 北京德默高科医药技术有限公司 含有布洛芬或其结构类似物的多层经皮给药系统
RU2705896C1 (ru) * 2019-07-26 2019-11-12 Артем Олегович Бахметьев Трансдермальный пластырь
US11471839B2 (en) * 2019-08-06 2022-10-18 Uop Llc High selectivity membranes for hydrogen sulfide and carbon dioxide removal from natural gas
EP4135687A4 (en) * 2020-04-17 2024-04-17 Univ Connecticut POLYCANNABINOIDS, COMPOUNDS, COMPOSITIONS AND METHODS OF USE
US20210346207A1 (en) * 2020-05-11 2021-11-11 Marc Sheldon Stevens Four-way stretch therapeutic compress assembly, system, and method
WO2022170171A1 (en) * 2021-02-07 2022-08-11 Lumen Catheters, LLC Antimicrobial light-emitting percutaneous site dressing

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1880808A (en) 1927-03-28 1932-10-04 Eastman Kodak Co Process of making cellulose esters of carboxylic acids
US1683347A (en) 1927-08-25 1928-09-04 Eastman Kodak Co Process of making chloroform-soluble cellulose acetate
US1698049A (en) 1928-01-18 1929-01-08 Eastman Kodak Co Process of making cellulosic esters containing halogen-substituted fatty-acid groups
US1984147A (en) 1929-10-22 1934-12-11 Eastman Kodak Co Process for the production of cellulose esters and corresponding alkyl esters
US1880560A (en) 1929-12-14 1932-10-04 Eastman Kodak Co Process for the hydrolysis of cellulose acetate
US2129052A (en) 1936-02-04 1938-09-06 Eastman Kodak Co Hydrolyzed cellulose acetate
US3493319A (en) 1967-05-26 1970-02-03 Us Agriculture Esterification of cellulosic textiles with unsaturated long chain fatty acids in the presence of trifluoroacetic anhydride using controlled cellulose-acid-anhydride ratios
DE3634016A1 (de) * 1986-04-17 1987-10-29 Lohmann Gmbh & Co Kg Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung
ATE71287T1 (de) 1986-06-13 1992-01-15 Alza Corp Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
US5071656A (en) 1987-03-05 1991-12-10 Alza Corporation Delayed onset transdermal delivery device
US5538736A (en) * 1987-04-28 1996-07-23 Lts Lohmann Therapie-Systeme Gmbh Active substance-containing plaster for the controlled administration of active substances to the skin
DE3714140A1 (de) 1987-04-28 1988-11-10 Lohmann Therapie Syst Lts Wirkstoffhaltiges pflaster zur kontrollierten verabreichung von wirkstoffen an die haut, seine verwendung sowie verfahren zur gesteuerten verabreichung von wirkstoffen an die haut
US4787888A (en) * 1987-06-01 1988-11-29 University Of Connecticut Disposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a)
US5123900A (en) * 1991-08-16 1992-06-23 Bertek, Inc. Moisture permeable double disk
US5246705A (en) 1992-04-08 1993-09-21 Cygnus Therapeutic System Occlusive, elastomeric backing materials in transdermal drug delivery systems, and associated methods of manufacture and use
US5612411A (en) * 1992-11-18 1997-03-18 Kimberly-Clark Corporation Absorbent phycocolloids and a method for their manufacture
US5489624A (en) * 1992-12-01 1996-02-06 Minnesota Mining And Manufacturing Company Hydrophilic pressure sensitive adhesives
US5567489A (en) * 1993-09-16 1996-10-22 The Dow Chemical Company Multilayer halogen-free barrier film for ostomy and transdermal drug delivery applications
US5635203A (en) 1994-09-29 1997-06-03 Alza Corporation Transdermal device having decreased delamination
EP0799029A1 (en) * 1994-12-21 1997-10-08 Theratech, Inc. Transdermal delivery system with adhesive overlay and peel seal disc
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US6174545B1 (en) * 1997-07-01 2001-01-16 Alza Corporation Drug delivery devices and process of manufacture
DE19820999A1 (de) * 1998-05-11 1999-11-18 Lohmann Therapie Syst Lts Laminat zum Aufbringen auf einen Akzeptor
RU2276998C2 (ru) 2001-05-01 2006-05-27 Институт Нефтехимического Синтеза Имени А.В. Топчиева Российской Академии Наук Гидрогелевые композиции
US20040024028A1 (en) 2001-08-02 2004-02-05 Burton Steven L. Method for reducing or eliminating smoking
DE10159745A1 (de) 2001-12-05 2003-07-03 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort
KR20050059072A (ko) 2002-08-30 2005-06-17 알자 코포레이션 엠보싱 및 기록가능한 다층 지지 구조물
BRPI0407615B8 (pt) 2003-02-21 2021-05-25 Bayer Ip Gmbh sistema terapêutico transdérmico estável à radiação ultravioleta
TW200628175A (en) 2004-10-08 2006-08-16 Noven Pharma Transdermal drug delivert device including an occlusive backing
JP2008259629A (ja) 2007-04-11 2008-10-30 Hakujuji Co Ltd 傷保護材
WO2009026135A2 (en) 2007-08-17 2009-02-26 Alza Corporation Controlled transdermal bisoprolol delivery system
CN100560157C (zh) * 2007-11-13 2009-11-18 重庆市生力医疗设备有限公司 超声波药贴
EP2315569B1 (en) * 2008-06-13 2016-09-14 Oragenics, Inc. Use of hydrogen peroxide-producing bacteria for tooth whitening
CN101518599A (zh) * 2009-03-24 2009-09-02 沈阳药科大学 祖师麻提取物缓释贴剂及其制备方法
TWI433904B (zh) 2011-01-12 2014-04-11 Taiwan Biotech Co Ltd 多奈哌齊經皮貼片
BR112014014828A2 (pt) 2011-12-21 2017-06-13 3M Innovative Properties Co conjunto de emplastros adesivos com revestimento de sobreposição e sistema e método para a produção do mesmo
KR101239150B1 (ko) 2012-02-28 2013-03-06 에스케이케미칼주식회사 도네페질-함유 경피흡수제제 및 그의 제조방법
US20140276479A1 (en) * 2013-03-14 2014-09-18 Noven Pharmaceuticals, Inc. Transdermal drug delivery system with overlay
KR101485822B1 (ko) 2014-01-22 2015-01-23 주식회사 대웅제약 도네페질 또는 그의 염을 함유하는 경피흡수제제
PL3235494T3 (pl) 2014-12-18 2020-08-24 Icure Pharmaceutical Inc. Preparat transdermalny zawierający donepezil jako składnik aktywny
US10835499B2 (en) * 2015-12-30 2020-11-17 Corium, Inc. Systems and methods for long term transdermal administration

Also Published As

Publication number Publication date
RU2018127642A (ru) 2020-02-03
US10966936B2 (en) 2021-04-06
AU2016381351A1 (en) 2018-07-19
US20170189534A1 (en) 2017-07-06
IL260290B1 (en) 2023-07-01
AU2016381351B2 (en) 2022-09-29
IL260290A (en) 2018-07-31
CA3010183A1 (en) 2017-07-06
IL260290B2 (en) 2023-11-01
US20210196650A1 (en) 2021-07-01
US10835499B2 (en) 2020-11-17
US11648214B2 (en) 2023-05-16
JP2019504052A (ja) 2019-02-14
RU2737464C2 (ru) 2020-11-30
CN108697655B (zh) 2021-12-10
CN108697655A (zh) 2018-10-23
KR20180127315A (ko) 2018-11-28
US20240108587A1 (en) 2024-04-04
US20210023020A1 (en) 2021-01-28
RU2018127642A3 (es) 2020-05-13
US20240091168A1 (en) 2024-03-21
JP6833855B2 (ja) 2021-02-24
SG11201805570WA (en) 2018-07-30
AU2022235539A1 (en) 2022-10-13
US11679086B2 (en) 2023-06-20
EP3397250A1 (en) 2018-11-07
IL303255A (en) 2023-07-01
WO2017117554A1 (en) 2017-07-06
US20170189348A1 (en) 2017-07-06

Similar Documents

Publication Publication Date Title
MX2018008190A (es) Sistemas y metodos para la administracion transdermica a largo plazo.
MX2018012486A (es) Composiciones para aplicacion topica de compuestos.
CA2956871C (en) Compounds active towards bromodomains
NZ742208A (en) Topical pharmaceutical formulations for treating inflammatory-related conditions
MY195009A (en) Cellular Targeted Active Ingredient Delivery System
MX2018013983A (es) Inhibidores g12c de kras.
MX2023006706A (es) Administracion transdermica de agentes grandes en composiciones de emulsion mediante acondicionamiento de la piel con microagujas y sus usos.
EP3723852A4 (en) DYNAMIC DOSING SYSTEMS FOR PHOTOTHERAPY AND RELATED DEVICES, SYSTEMS AND PROCEDURES
EP3310392A4 (en) VASELINE ADMINISTRATION SYSTEMS FOR ACTIVE INGREDIENTS
MX2022004304A (es) Agentes inductores de apoptosis.
EP3160554A4 (en) Methods, devices and systems for pulmonary delivery of active agents
EP3913896A3 (en) Service layer session migration and sharing
GB2541571A (en) Pharmaceutical compositions
SG10201902326XA (en) Mk2 inhibitors and uses thereof
TN2015000411A1 (en) Ceftolozane antibiotic compositions
EA201791454A1 (ru) Лекарственные формы для трансдермального введения
PH12018502154A1 (en) Methods of treating ocular conditions
EP3405151A4 (en) IMPROVED TRANSDERMAL DISTRIBUTION OF ACTIVE SUBSTANCES
PH12017500602A1 (en) Methods for treating ocular conditions
AU2016361427A8 (en) Platinum anticancer agents
MX2021006326A (es) Inhibidores de pcna.
MX2021006102A (es) Suministro mejorado de agentes grandes.
MX2016004078A (es) Formulacion de atazanavir y cobicistat para el tratamiento del virus de inmunodeficiencia humana (vih).
EP3654844A4 (en) DEVICES, SYSTEMS AND METHODS FOR DISPENSING SOLID FORMULATIONS
PH12019502145A1 (en) Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient